genes essenciais de cryptococcus
The present invention relates to methods for identifying and validating gene products from the Cryptococcus fungus as effective targets for therapeutic drug screening. The use of five genes identified in Cryptococcus, responsible for the production of nucleolar protein 16 (NOP16), a scramblase, otub...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RAFAEL SCHNEIDER MÁRCIO L. RODRIGUES CHARLEY CHRISTIAN STAATS MARCIO L. RODRIGUES LUNA SOBRINO JOFFE MARILENE HENNING VAINSTEIN LIVIA KMETZSCH ROSA E SILVA AUGUSTO SCHRANK LÍVIA KMETZSCH ROSA E SILVA |
| description | The present invention relates to methods for identifying and validating gene products from the Cryptococcus fungus as effective targets for therapeutic drug screening. The use of five genes identified in Cryptococcus, responsible for the production of nucleolar protein 16 (NOP16), a scramblase, otubain-1, beta DNA-polymerase and a hypothetical protein, proved to be useful for studying metabolic pathways for the growth, proliferation and survival of C. neoformans or C. gattii, for pigmentation, as well as the production of cellular or extracellular subproducts that are important for the pathogenicity and virulence of the microrganism. Cryptococcus wild-type strains or strains that suffered mutation for the interruption of genes were used to screen compounds with antifungal activity. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR102017004730A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR102017004730A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR102017004730A23</originalsourceid><addsrcrecordid>eNrjZFBIT81LLVZILS5OzUvOTMwsVkhJVUguqiwoyU_OT04uLeZhYE1LzClO5YXS3Ayqbq4hzh66qQX58anFBYnJQANK4p2CDA2MDAzNDQxMzI0NHI2MiVUHAJS5Jw4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>genes essenciais de cryptococcus</title><source>esp@cenet</source><creator>RAFAEL SCHNEIDER ; MÁRCIO L. RODRIGUES ; CHARLEY CHRISTIAN STAATS ; MARCIO L. RODRIGUES ; LUNA SOBRINO JOFFE ; MARILENE HENNING VAINSTEIN ; LIVIA KMETZSCH ROSA E SILVA ; AUGUSTO SCHRANK ; LÍVIA KMETZSCH ROSA E SILVA</creator><creatorcontrib>RAFAEL SCHNEIDER ; MÁRCIO L. RODRIGUES ; CHARLEY CHRISTIAN STAATS ; MARCIO L. RODRIGUES ; LUNA SOBRINO JOFFE ; MARILENE HENNING VAINSTEIN ; LIVIA KMETZSCH ROSA E SILVA ; AUGUSTO SCHRANK ; LÍVIA KMETZSCH ROSA E SILVA</creatorcontrib><description>The present invention relates to methods for identifying and validating gene products from the Cryptococcus fungus as effective targets for therapeutic drug screening. The use of five genes identified in Cryptococcus, responsible for the production of nucleolar protein 16 (NOP16), a scramblase, otubain-1, beta DNA-polymerase and a hypothetical protein, proved to be useful for studying metabolic pathways for the growth, proliferation and survival of C. neoformans or C. gattii, for pigmentation, as well as the production of cellular or extracellular subproducts that are important for the pathogenicity and virulence of the microrganism. Cryptococcus wild-type strains or strains that suffered mutation for the interruption of genes were used to screen compounds with antifungal activity.</description><language>por</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; COMPOSITIONS THEREOF ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; CULTURE MEDIA ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181030&DB=EPODOC&CC=BR&NR=102017004730A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181030&DB=EPODOC&CC=BR&NR=102017004730A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RAFAEL SCHNEIDER</creatorcontrib><creatorcontrib>MÁRCIO L. RODRIGUES</creatorcontrib><creatorcontrib>CHARLEY CHRISTIAN STAATS</creatorcontrib><creatorcontrib>MARCIO L. RODRIGUES</creatorcontrib><creatorcontrib>LUNA SOBRINO JOFFE</creatorcontrib><creatorcontrib>MARILENE HENNING VAINSTEIN</creatorcontrib><creatorcontrib>LIVIA KMETZSCH ROSA E SILVA</creatorcontrib><creatorcontrib>AUGUSTO SCHRANK</creatorcontrib><creatorcontrib>LÍVIA KMETZSCH ROSA E SILVA</creatorcontrib><title>genes essenciais de cryptococcus</title><description>The present invention relates to methods for identifying and validating gene products from the Cryptococcus fungus as effective targets for therapeutic drug screening. The use of five genes identified in Cryptococcus, responsible for the production of nucleolar protein 16 (NOP16), a scramblase, otubain-1, beta DNA-polymerase and a hypothetical protein, proved to be useful for studying metabolic pathways for the growth, proliferation and survival of C. neoformans or C. gattii, for pigmentation, as well as the production of cellular or extracellular subproducts that are important for the pathogenicity and virulence of the microrganism. Cryptococcus wild-type strains or strains that suffered mutation for the interruption of genes were used to screen compounds with antifungal activity.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>COMPOSITIONS THEREOF</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBIT81LLVZILS5OzUvOTMwsVkhJVUguqiwoyU_OT04uLeZhYE1LzClO5YXS3Ayqbq4hzh66qQX58anFBYnJQANK4p2CDA2MDAzNDQxMzI0NHI2MiVUHAJS5Jw4</recordid><startdate>20181030</startdate><enddate>20181030</enddate><creator>RAFAEL SCHNEIDER</creator><creator>MÁRCIO L. RODRIGUES</creator><creator>CHARLEY CHRISTIAN STAATS</creator><creator>MARCIO L. RODRIGUES</creator><creator>LUNA SOBRINO JOFFE</creator><creator>MARILENE HENNING VAINSTEIN</creator><creator>LIVIA KMETZSCH ROSA E SILVA</creator><creator>AUGUSTO SCHRANK</creator><creator>LÍVIA KMETZSCH ROSA E SILVA</creator><scope>EVB</scope></search><sort><creationdate>20181030</creationdate><title>genes essenciais de cryptococcus</title><author>RAFAEL SCHNEIDER ; MÁRCIO L. RODRIGUES ; CHARLEY CHRISTIAN STAATS ; MARCIO L. RODRIGUES ; LUNA SOBRINO JOFFE ; MARILENE HENNING VAINSTEIN ; LIVIA KMETZSCH ROSA E SILVA ; AUGUSTO SCHRANK ; LÍVIA KMETZSCH ROSA E SILVA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR102017004730A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2018</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>COMPOSITIONS THEREOF</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>RAFAEL SCHNEIDER</creatorcontrib><creatorcontrib>MÁRCIO L. RODRIGUES</creatorcontrib><creatorcontrib>CHARLEY CHRISTIAN STAATS</creatorcontrib><creatorcontrib>MARCIO L. RODRIGUES</creatorcontrib><creatorcontrib>LUNA SOBRINO JOFFE</creatorcontrib><creatorcontrib>MARILENE HENNING VAINSTEIN</creatorcontrib><creatorcontrib>LIVIA KMETZSCH ROSA E SILVA</creatorcontrib><creatorcontrib>AUGUSTO SCHRANK</creatorcontrib><creatorcontrib>LÍVIA KMETZSCH ROSA E SILVA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RAFAEL SCHNEIDER</au><au>MÁRCIO L. RODRIGUES</au><au>CHARLEY CHRISTIAN STAATS</au><au>MARCIO L. RODRIGUES</au><au>LUNA SOBRINO JOFFE</au><au>MARILENE HENNING VAINSTEIN</au><au>LIVIA KMETZSCH ROSA E SILVA</au><au>AUGUSTO SCHRANK</au><au>LÍVIA KMETZSCH ROSA E SILVA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>genes essenciais de cryptococcus</title><date>2018-10-30</date><risdate>2018</risdate><abstract>The present invention relates to methods for identifying and validating gene products from the Cryptococcus fungus as effective targets for therapeutic drug screening. The use of five genes identified in Cryptococcus, responsible for the production of nucleolar protein 16 (NOP16), a scramblase, otubain-1, beta DNA-polymerase and a hypothetical protein, proved to be useful for studying metabolic pathways for the growth, proliferation and survival of C. neoformans or C. gattii, for pigmentation, as well as the production of cellular or extracellular subproducts that are important for the pathogenicity and virulence of the microrganism. Cryptococcus wild-type strains or strains that suffered mutation for the interruption of genes were used to screen compounds with antifungal activity.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BR102017004730A2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | genes essenciais de cryptococcus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T14%3A22%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RAFAEL%20SCHNEIDER&rft.date=2018-10-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR102017004730A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |